Tag: Cancer: Misc.
FDA Approves First Biosimilar Drug in U.S.
Zarxio is highly similar to long-sanctioned cancer drug
February 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2015. This roundup includes...
Oral Bisphosphonate Use Tied to Lower Endometrial Cancer Risk
Reduction in endometrial cancer risk with ever use in large cohort of postmenopausal women
Nasal Allergies Tied to Increased Nasopharyngeal Cancer Risk
Even higher risk seen for patients with repeated visits for allergic rhinitis
FDA Approves Farydak for Multiple Myeloma
Drug is sanctioned for people who have received at least two prior standard therapies
Americans Living Longer Post-Cancer, but Disparities Remain
Study shows biggest improvements in people diagnosed between ages 50 and 64
Research Finds No Cancer Link With Pimecrolimus
Company-funded research followed nearly 7,500 children over 10 years
Cancer Survivors Need Healthful Lifestyle Advice
Oncology care teams should provide guidance on lifestyle change as part of survivorship care
Cancer Patients Rarely Demand Unnecessary Treatment, Tests
Doctors' claims that this is fueling increasing health costs unwarranted
ASA: Cancer Risk Higher for Older Stroke Survivors
But cancer only affected about 2 percent of those in two-year follow-up period
